Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
Clinical trial NCT03001557 · COMPLETED
Trial details
- NCT number
- NCT03001557
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2018-07-26
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.